Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis

Fibulin-3 has emerged as a promising novel biomarker in conforming or monitoring malignant pleural mesothelioma (MPM). This study sought to evaluate the diagnostic and prognostic efficacies of humoral fibulin-3 for MPM. Seven eligible publications comprising 468 MPM cases for diagnosis, and 138 for...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Dongxu, Li, Yongwei, Liu, Xinwei, Yan, Sha, Guo, Xiaolan, Xu, Xiaona, Guo, Xiaoxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355074/
https://www.ncbi.nlm.nih.gov/pubmed/28103581
http://dx.doi.org/10.18632/oncotarget.14712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355074/
https://www.ncbi.nlm.nih.gov/pubmed/28103581
http://dx.doi.org/10.18632/oncotarget.14712

Ejemplares similares